Twitter LinkedIn
    Friday, February 3
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Funds»Singapore-based Impact Investor Heritas Capital holds USD60m first close of Heritas Growth Fund III
    Funds

    Singapore-based Impact Investor Heritas Capital holds USD60m first close of Heritas Growth Fund III

    June 1, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Heritas Capital (Heritas) has just held the first close of its third private equity fund, Heritas Growth Fund III (Fund III), at USD60 million.

    The first close follows Heritas Capital’s announcement early this year of its plan to launch a USD150 million Fund III as a Pan-Asia Impact Fund focusing on high impact sectors within Healthcare, Education and Technology for building back better post-Covid-19. Fund III seeks to back 10-15 emerging Asian champions with innovative and impactful solutions aligned with selected UN SDG Goals. Ticket sizes for each Fund III investment may range from USD5 million to USD20 million, targeting high growth businesses seeking Series B financing and beyond to advance their solutions at-scale.

    The launch of Fund III builds on Heritas’ successful track record of earlier Growth Funds which have deployed USD150 million to back smart platform solutions such as omni-channel healthcare and education solutions, next generation therapeutics, and precision medicine. Heritas has achieved post-investment value creation by supporting founders and management teams in their growth journey, leveraging Heritas’ domain expertise, industry networks, sound governance and sustainable ESG / impact practices. Examples of Heritas-backed category leaders which have shown strong traction and resilience notwithstanding Covid-19 and continued to serve their respective communities with purpose include: Q&M Dental (dental chain, Singapore), Timberland Medical Centre (private hospital, Malaysia), Alodoktor (telehealth, Indonesia), MFine (telehealth, India), and BHL Education (K-12 education, Vietnam). The latest investment by Heritas Capital was its follow-on participation in the USD125 million Series C round of Hummingbird Bioscience announced in May 2021 through Fund II, having been an early backer since Series A and B rounds via its Heritas Venture Fund (HVF) since 2019.

    Fund III is set up as the first sub-fund under Heritas-managed Variable Capital Company (VCC), a new corporate structure tailored for investment funds using Singapore as a base for fund management and domiciliation. As a Capital Markets Services License Holder regulated by the Monetary Authority of Singapore, Heritas values the operational flexibility, sound governance and tax advantages offered by VCC and will be evaluating additional impact-oriented sub-funds such as Venture Capital, SPACs and Development Impact Bonds in the future.

    Read more/Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Fundraising funds PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    KKR looking to sell Canadian gas producer Westbrick for $1.13B

    November 18, 2022

    Carlyle targeting $1.6B for second renewables fund

    November 18, 2022

    Comments are closed.

    Other Articles

    How private equity came to dominate the sports world (and why it could all end in tears)

    December 30, 2021

    Investment manager to pursue IPO next month

    January 12, 2021

    Barings and Partners Group provide financing to support Arcline’s CoreDux acquisition

    July 6, 2022

    Morgan Stanley Raises $2bn for Latest Private Equity Fund

    March 2, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?